Page 1173 - Cote clinical veterinary advisor dogs and cats 4th
P. 1173

586   Leukemias, Acute


            metabolic, nutritional/neoplastic, infectious/  •  Echocardiogram     PROGNOSIS & OUTCOME
            inflammatory/ischemic/immune-mediated,   •  CT or MRI                Prognosis depends on the cause. The patient
  VetBooks.ir  •  VINDICATE’M scheme: vascular, infectious/   TREATMENT          and diagnostic plan need to be re-evaluated if
            trauma/toxin, vascular disease
                                                                                 clinical signs persist or worsen despite initial
            inflammatory, neoplastic, degenerative/
            deficiency/drugs, idiopathic/intoxication/
                                              Treatment should be targeted to the defini-
            iatrogenic, congenital, autoimmune/allergic/   Treatment Overview    treatment.
            anatomic, traumatic, endocrine or environ-  tive or suspected diagnosis and/or aid in the    PEARLS & CONSIDERATIONS
            mental, metabolic                 comfort of the patient. For most situations,
                                              antibiotics, glucocorticoids, and nonsteroidal   Comments
           Initial Database                   antiinflammatory drugs (NSAIDs) should be   Glucocorticoids  and  NSAIDs  inhibit  the
           •  CBC, serum biochemistry profile, urinalysis   withheld until a diagnosis is reached or when   arachidonic acid cascade and therefore essential
            with sediment exam                the potential benefits greatly outweigh patient   prostaglandins.  Inhibition of prostaglandins
           •  Noninvasive blood pressure      risk (e.g., broad-spectrum antibiotics for fever   may result in damage to the protective GI
           •  Retroviral testing (cats): feline leukemia virus/  of unknown origin).  mucosal barrier and acute kidney injury.
            feline immunodeficiency virus (FeLV/FIV)                             These treatments should be recommended on
                                              Acute General Treatment            a case-by-case basis and should be avoided in
           Advanced or Confirmatory Testing   •  Ideally, treatment should be specific to the   situations of malperfusion or shock.
           Advanced testing depends on the results of   underlying disease process.
           initial diagnostic tests but may include:  •  Symptomatic outpatient therapy (e.g., bland     Technician Tips
           •  Diagnostic  imaging:  thoracic/abdominal   diet, gastroprotectants,  ± antiemetic for   Serial  physical  exams  may  aid  in  disease  or
            radiographs, abdominal ultrasound   animals with GI signs) may be appropri-  problem localization. Frequent evaluation of
           •  Arterial or venous blood gas exam  ate for patients showing mild, nonspecific     mental status, respiratory rate/effort, pulse rate/
           •  Endocrine testing: ACTH stimulation test,   signs.                 strength, and comfort is essential.
            thyroxine/thyroid-stimulating hormone (T 4 /  •  Antibiotics should be administered only if
            TSH), low-dose dexamethasone suppression   infection is documented or highly suspected.   SUGGESTED READING
            test (LDDST)                        Antibiotic  choice  should  be  based  on  the   Brewer FC: Weakness. In Ettinger SJ, et al, editors:
           •  Fluid analysis (abdominal, thoracic, joint,   likely pathogen, confirmed by culture and   Textbook of veterinary internal medicine, ed 8, St.
            cerebrospinal fluid [CSF])          sensitivity, and de-escalated when possible.  Louis, Saunders, 2017, pp 91-94.
           •  Infectious  disease  testing/titers:  consider                     AUTHOR: Meghan Harmon, DVM, DACVECC
            regional prevalence, additional clues (e.g.,   Possible Complications  EDITOR: Leah A. Cohn, DVM, PhD, DACVIM
            puppy – parvovirus ELISA; Lyme serology   Client follow-up is essential in cases of non-
            in northeastern United States)    specific lethargy because failure to respond to
           •  Cytology  or  histopathology  (fine-needle   empirical therapy or time may warrant addi-
            aspiration, bone marrow biopsy)   tional diagnostics, treatment, and/or referral.







            Leukemias, Acute                                                                       Client Education
                                                                                                         Sheet


            BASIC INFORMATION                 •  Myelodysplastic syndromes can progress to   PHYSICAL EXAM FINDINGS
                                                AML.                             •  Lethargy,  weakness,  pallor,  weight  loss,
           Definition                                                              dehydration
           Acute leukemias (ALs) are clonal proliferations   ASSOCIATED DISORDERS  •  Fever
           of malignant immature lymphoid or hemato-  •  ALL in dogs: hypercalcemia  •  Tachypnea/dyspnea, tachycardia (anemia)
           poietic (myeloid) progenitor cells in the bone   •  AML in cats: myelofibrosis, hypercalcemia,   •  Hepatomegaly, splenomegaly
           marrow/blood.                        glomerulonephritis               •  Lymphadenopathy (mild)
                                                                                 •  Petechiae,  ecchymoses,  epistaxis,  gastro-
           Epidemiology                       Clinical Presentation                intestinal (GI) bleeding
           SPECIES, AGE, SEX                  DISEASE FORMS/SUBTYPES             •  Hyphema, uveitis, retinal hemorrhage
           •  Young  cats  and  dogs  more  commonly   Acute Lymphoid Leukemias:  •  Neurologic signs
            affected;  acute  lymphoblastic  leukemias   •  Contradictory  reports  of  most  common
            (ALLs) in dogs: median age of 7 years  phenotype in dogs             Etiology and Pathophysiology
           •  Purebred large-breed dogs predominate (e.g.,   •  T-cell  leukemia:  most  common  immuno-  •  ALs  are  diseases  of  the  bone  marrow.
            German shepherd dogs and retrievers).  phenotype in cats               Leukemic cells crowd normal cells, change
                                              Acute myeloid leukemias:             the marrow microenvironment, and secrete
           RISK FACTORS                       •  Reports suggest more common than ALL  suppressor factors (myelophthisis). Normal
           •  Feline  leukemia  virus  (FeLV)  infection:   •  Classified based on type of blasts (p. 1432)  hematopoiesis decreases, causing anemia,
            historically, > 60% of cats with ALL were                              neutropenia,  and  thrombocytopenia.
            FeLV positive and  ≥  90%  of  cats  with   HISTORY, CHIEF COMPLAINT   Cytopenias result in weakness, secondary
            acute myeloid leukemias (AMLs) were   •  Lethargy, weakness, inappetance, weight loss  infections, and hemorrhage.
            FeLV positive. Current infection rates   •  Vomiting, diarrhea       •  Hepatic  and  splenic  infiltration  results  in
            are unknown but thought to be lower    •  Hemorrhage (e.g., epistaxis, petechiae)  organomegaly, abdominal distention, and loss
            (p. 329).                         •  Lameness (bone pain)              of appetite. Other sites may be involved,
                                                     www.ExpertConsult.com
   1168   1169   1170   1171   1172   1173   1174   1175   1176   1177   1178